Pharmasyntez the largest Russian manufacturer of the socially significant pharmaceuticals.
Five factories in Russia: Saint Petersburg, Tyumen, Bratsk, Irkutsk, Ussuriysk
The company's portfolio includes the following medicines:
• HIV/AIDS drugs;
• NSAIDs;
• Endocrine medicines (antidiabetic, hormonal, fertility drugs and others);
• Cardiovascular drugs;
• COVID-19 drugs;
• Oncology drugs;
• Antipsychotics;
• Antibiotics, Antiviral and Antituberculosis;
• Anesthetic drugs and X-ray agents;
• Drugs for Rare Disease
more >
Year of Establishment:
1997
Total Assets(USD):
More than 99,999,999
Total Number of Staff:
more than 1000
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Distributor,Manufacturer
R&D capacity:
OEM,ODM,Own Brand
Annual Turnover(USD):
More than 99,999,999
Main Sales Markets:
Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: